Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs

NCT04727723 · clinicaltrials.gov ↗

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroenteropancreatic Neuroendocrine Tumor

Interventions

DRUG: Lutathera®

Sponsor

Novartis Pharmaceuticals